Skip Ribbon Commands
Skip to main content

Allergy Testing

Nearly 60% of asthmatic adults and 90% of asthmatic children have allergy triggers that may lead to full-blown respiratory distress. 1,2

Why Test With ImmunoCAP?

Between 80-85% of asthma and upper respiratory diseases are managed by primary care clinicians.3 With ImmunoCAP in-vitro test, the presence of IgE antibodies to allergens in the blood can quickly be determined.

Test Benefits 

  • Confirms or excludes the presence of allergies 
  • Identifies specific allergens to avoid 
  • Allergy panels specifically designed for our Pacific Northwest region 
  • Potentially eliminates unnecessary medications, since 65% of patients taking non-sedating antihistamines are not allergic.4

Create an allergy action plan for your patient! 

Back to top ​​​